| EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris–Part 1: treatment and monitoring recommendations A Nast, C Smith, PI Spuls, G Avila Valle, Z Bata‐Csörgö, H Boonen, ... Journal of the European Academy of Dermatology and Venereology 34 (11), 2461 …, 2020 | 257* | 2020 |
| Escaping the stem cell compartment: Sustained UVB exposure allows p53-mutant keratinocytes to colonize adjacent epidermal proliferating units without incurring … W Zhang, E Remenyik, D Zelterman, DE Brash, NM Wikonkal Proceedings of the National Academy of Sciences 98 (24), 13948-13953, 2001 | 192 | 2001 |
| Atorvastatin effect on high-density lipoprotein-associated paraoxonase activity and oxidative DNA damage M Harangi, I Seres, Z Varga, G Emri, Z Szilvássy, G Paragh, É Remenyik European Journal of Clinical Pharmacology 60, 685-691, 2004 | 111 | 2004 |
| PPARγ-mediated and arachidonic acid–dependent signaling is involved in differentiation and lipid production of human sebocytes A Dozsa, B Dezso, BI Toth, A Bacsi, S Poliska, E Camera, M Picardo, ... Journal of Investigative Dermatology 134 (4), 910-920, 2014 | 97 | 2014 |
| Exploring the relationship between EQ-5D, DLQI and PASI, and mapping EQ-5D utilities: a cross-sectional study in psoriasis from Hungary E Herédi, F Rencz, O Balogh, L Gulácsi, K Herszényi, P Holló, H Jókai, ... The European Journal of Health Economics 15, 111-119, 2014 | 93 | 2014 |
| Inactivating E2f1 reverts apoptosis resistance and cancer sensitivity in Trp53-deficient mice NM Wikonkal, E Remenyik, D Knezevic, W Zhang, M Liu, H Zhao, ... Nature cell biology 5 (7), 655-660, 2003 | 91 | 2003 |
| Ultraviolet radiation-mediated development of cutaneous melanoma: An update G Emri, G Paragh, Á Tósaki, E Janka, S Kollár, C Hegedűs, E Gellén, ... Journal of Photochemistry and Photobiology B: Biology 185, 169-175, 2018 | 90 | 2018 |
| bcl-2 vs p53 protein expression and apoptotic rate in human nonmelanoma skin cancers NM Wikonkal, RJW Berg, CW van Haselen, I Horkay, E Remenyik, ... Archives of dermatology 133 (5), 599-602, 1997 | 85 | 1997 |
| Interleukin-8 is induced in skin equivalents and is highest in those derived from psoriatic fibroblasts NV Konstantinova, DMT Duong, E Remenyik, P Hazarika, A Chuang, ... Journal of investigative dermatology 107 (4), 615-621, 1996 | 74 | 1996 |
| Sebocytes differentially express and secrete adipokines D Kovács, M Lovászi, S Póliska, A Oláh, T Bíró, I Veres, CC Zouboulis, ... Experimental dermatology 25 (3), 194-199, 2016 | 70 | 2016 |
| Determination of DNA damage induced by oxidative stress in hyperlipidemic patients M Harangi, É Remenyik, I Seres, Z Varga, E Katona, G Paragh Mutation Research/Genetic Toxicology and Environmental Mutagenesis 513 (1-2 …, 2002 | 65 | 2002 |
| A randomized phase 3b/4 study to evaluate concomitant use of topical ivermectin 1% cream and doxycycline 40-mg modified-release capsules, versus topical ivermectin 1% cream and … M Schaller, L Kemény, B Havlickova, JM Jackson, M Ambroziak, C Lynde, ... Journal of the American Academy of Dermatology 82 (2), 336-343, 2020 | 59 | 2020 |
| A detailed analysis of ‘not relevant’responses on the DLQI in psoriasis: potential biases in treatment decisions F Rencz, AK Poór, M Péntek, P Holló, S Kárpáti, L Gulácsi, A Szegedi, ... Journal of the European Academy of Dermatology and Venereology 32 (5), 783-790, 2018 | 58 | 2018 |
| Proposal of a new scoring formula for the Dermatology Life Quality Index in psoriasis F Rencz, L Gulácsi, M Péntek, AK Poór, M Sárdy, P Holló, A Szegedi, ... British Journal of Dermatology 179 (5), 1102-1108, 2018 | 57 | 2018 |
| Leptin promotes a proinflammatory lipid profile and induces inflammatory pathways in human SZ95 sebocytes D Törőcsik, D Kovács, E Camera, M Lovászi, K Cseri, GG Nagy, ... British Journal of Dermatology 171 (6), 1326-1335, 2014 | 57 | 2014 |
| The DNA damage signal for Mdm2 regulation, Trp53 induction, and sunburn cell formation in vivo originates from actively transcribed genes DE Brash, NM Wikonkal, E Remenyik, GTJ Van der Horst, EC Friedberg, ... Journal of investigative dermatology 117 (5), 1234-1240, 2001 | 55 | 2001 |
| Treatment of pemphigus vulgaris and foliaceus with efgartigimod, a neonatal Fc receptor inhibitor: a phase II multicentre, open‐label feasibility trial M Goebeler, Z Bata‐Csörgő, C De Simone, B Didona, E Remenyik, ... British Journal of Dermatology 186 (3), 429-439, 2022 | 54 | 2022 |
| Cost-of-illness in patients with moderate to severe psoriasis: a cross-sectional survey in Hungarian dermatological centres O Balogh, V Brodszky, L Gulácsi, E Herédi, K Herszényi, H Jókai, ... The European Journal of Health Economics 15, 101-109, 2014 | 48 | 2014 |
| Correlation among metallothionein expression, intratumoural macrophage infiltration and the risk of metastasis in human cutaneous malignant melanoma E Emri, K Egervari, T Varvolgyi, D Rozsa, E Miko, B Dezso, I Veres, ... Journal of the European Academy of Dermatology and Venereology 27 (3), e320-e327, 2013 | 47 | 2013 |
| Successful immunomodulatory therapy in castleman disease with paraneoplastic pemphigus vulgaris Z Miltenyi, J Toth, A Gonda, I Tar, E Remenyik, A Illes Pathology & Oncology Research 15, 375-381, 2009 | 44 | 2009 |
Andrea SzegediTanszékvezető egyetemi tanár, Debreceni Egyetem ÁOK, Bőrgyógyászati Tanszék, BőrgyógyászatiVerified email at med.unideb.hu
